Literature DB >> 16483874

Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids.

Gustavo Bajotto1, Taro Murakami, Masaru Nagasaki, Bolin Qin, Yoshiyuki Matsuo, Ken Maeda, Masayo Ohashi, Yoshiharu Oshida, Yuzo Sato, Yoshiharu Shimomura.   

Abstract

The activity of the pyruvate dehydrogenase complex (PDC) is regulated by covalent modification of its E1 component, which is catalyzed by specific pyruvate dehydrogenase kinases (PDKs) and phosphatases. In the liver, PDK2 and PDK4 are the most abundant PDK isoforms, which are responsible for inactivation of PDC when glucose availability is scarce in the body. In the present study, regulatory mechanisms of hepatic PDC were examined before and after the onset of type 2 diabetes mellitus in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, using Long-Evans Tokushima Otsuka (LETO) rats as controls. Plasma glucose and insulin concentrations were at normal levels in rats aged 8 weeks, but were significantly higher in OLETF than in LETO rats aged 25 weeks, indicating insulin resistance in OLETF rats. Plasma free fatty acids (FFAs) were 1.6-fold concentrated, and the liver PDC activity was significantly lower in OLETF than in LETO rats at both ages, suggesting suppression of pyruvate oxidative decarboxylation in OLETF rats before and after the onset of diabetes. Pyruvate dehydrogenase kinase activity and abundance of PDK2 and PDK4 proteins, as well as mRNAs, were greater in OLETF rats at both ages. These results suggest that persistently elevated levels of circulating free fatty acid in normal and diabetic OLETF rats play an important role in stimulating PDK2 and PDK4 expression in liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483874     DOI: 10.1016/j.metabol.2005.09.014

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs.

Authors:  Nikhil Adi; Jennipher Adi; Roberta Marques Lassance-Soares; Paul Kurlansky; Hong Yu; Keith A Webster
Journal:  J Diabetes Metab       Date:  2016-06-16

2.  Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice.

Authors:  Md Wasim Khan; Medha Priyadarshini; Jose Cordoba-Chacon; Thomas C Becker; Brian T Layden
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-12-10       Impact factor: 5.187

3.  Pyruvate Dehydrogenase Kinase 2 Accelerates Endotoxin Shock by Promoting Mitogen-Activated Protein Kinase Activation.

Authors:  Chunxia Li; Jun Dai; Chuanbin Liu; Guanjun Dong; Xin Zhang; Junfeng Zhang; Fenglian Yan; Hui Zhang; Changying Wang; Mingsheng Zhao; Zhaochen Ning; Qun Ma; Hui Shi; Zhihua Li; Huabao Xiong
Journal:  Inflammation       Date:  2022-09-29       Impact factor: 4.657

4.  Inhibition of protein kinase B by palmitate in the insulin signaling of HepG2 cells and the preventive effect of arachidonic acid on insulin resistance.

Authors:  Yanzhi Xia; Xuedong Wan; Qiuhong Duan; Shansu He; Ximing Wang
Journal:  Front Med China       Date:  2007-05-01

5.  Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice.

Authors:  Nam Ho Jeoung; Robert A Harris
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-22       Impact factor: 4.310

6.  Recognition of the inner lipoyl-bearing domain of dihydrolipoyl transacetylase and of the blood glucose-lowering compound AZD7545 by pyruvate dehydrogenase kinase 2.

Authors:  Alina Tuganova; Alla Klyuyeva; Kirill M Popov
Journal:  Biochemistry       Date:  2007-06-30       Impact factor: 3.162

7.  Impact of maternal undernutrition around the time of conception on factors regulating hepatic lipid metabolism and microRNAs in singleton and twin fetuses.

Authors:  Shervi Lie; Janna L Morrison; Olivia Williams-Wyss; Catherine M Suter; David T Humphreys; Susan E Ozanne; Song Zhang; Severence M MacLaughlin; David O Kleemann; Simon K Walker; Claire T Roberts; I Caroline McMillen
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

8.  Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesis.

Authors:  Yuko Katayama; Yayoi Kawata; Yusuke Moritoh; Masanori Watanabe
Journal:  Heliyon       Date:  2022-02-02

Review 9.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.